CALIFORNIA LIFE SCIENCES for CALIFORNIA LIFE SCIENCES
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Trade (domestic/foreign) TRD
Address concerns with India trade/IP policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| TODD E GILLENWATER | — |
Taxation/Internal Revenue Code TAX
Support repeal of medical device tax. Support extension of Therapeutic Discovery Tax Credit and R&D credit. Oppose repeal of Orphan Drug Tax Credit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| TODD E GILLENWATER | — |
Copyright/Patent/Trademark CPT
Address concerns with provisions of patent litigation reform, including Covered Business Method patents.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| TODD E GILLENWATER | — |
Health Issues HCR
Support legislation increasing access to wireless technologies. Address concerns regarding uncertainty and unpredictability of FDA drug and device regulatory environment. Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs. Address concerns with CMS Outpatient rule re skin substitute packaged payment/bundle.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| TODD E GILLENWATER | — |
Medicare/Medicaid MMM
Address concerns with Medicare Independent Payment Advisory Board (IPAB). Address concerns with changes to Medicare Part B and Part D programs, and 2014 Hospital Outpatient Prospective Payment System. Address concerns with CMS Outpatient rule re skin substitute packaged payment/bundle. Oppose changes to Medicare Advantage and Part D prescription drug benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| TODD E GILLENWATER | — |
Budget/Appropriations BUD
Labor/HHS/Ed Appropriations: NIH, biodefense/pandemic, science/math education, and strategic stockpile funding and preparation; FDA Appropriations; PTO Appropriations. FDA and PTO User Fee sequestration.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| TODD E GILLENWATER | — |
Immigration IMM
Support STEM-Ed/H-1B related provisions in any immigration reform measure.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| TODD E GILLENWATER | — |
Medical/Disease Research/Clinical Labs MED
Support NIH research funding. Support Kids First Research Act. Support Viral Hepatitis Testing Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JENNIFER NIETO CAREY | — |
| TODD E GILLENWATER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.